Skip to main content
Erschienen in: Japanese Journal of Radiology 12/2015

01.12.2015 | Original Article

Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres

verfasst von: Akihiko Seki, Shinichi Hori, Chigusa Shimono

Erschienen in: Japanese Journal of Radiology | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Contrast material pooling on angiography within a tumor bed during embolization for hepatocellular carcinoma (HCC) presents as the vascular lake (VL) phenomenon. This retrospective study aimed to evaluate the frequency and management of VLs during chemoembolization with drug-eluting beads (DEBs) and the relationship between the VL and local response.

Materials and methods

A total of 123 HCC patients without vascular invasion or intrahepatic metastases who underwent chemoembolization with DEBs (50–100 µm superabsorbent polymer microspheres loaded with epirubicin) were enrolled. Gelatin sponge particles (GS) were injected for additional embolization in limited patients with steadily increasing size of VLs during DEB injection. Overall, 338 nodules were divided into three groups: lesions without a VL (non-VL; n = 250); lesions with a VL but without additional GS embolization [VL–GS (−), n = 58]; and lesions with both VL and additional GS embolization [VL–GS (+); n = 30]. The local responses were statistically compared by Fisher’s exact test with the Bonferroni correction.

Results

The frequency of VLs was 26.0 % (88/338). The response rate in the non-VL group (54.0 %) was significantly lower than those in the VL–GS (−) (91.4 %; P < 0.0001) and VL–GS (+) (96.7 %; P < 0.0001) groups.

Conclusions

VL is a common angiographic finding and might be associated with the local response.
Literatur
1.
Zurück zum Zitat Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.PubMedCrossRef Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.PubMedCrossRef
2.
Zurück zum Zitat Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.PubMedCrossRef Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–9.PubMedCrossRef
3.
Zurück zum Zitat Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41–52.PubMedPubMedCentralCrossRef Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41–52.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Kritzinger J, Klass D, Ho S, Lim H, Buczkowski A, Yoshida E, et al. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol. 2013;68:1–15.PubMedCrossRef Kritzinger J, Klass D, Ho S, Lim H, Buczkowski A, Yoshida E, et al. Hepatic embolotherapy in interventional oncology: technology, techniques, and applications. Clin Radiol. 2013;68:1–15.PubMedCrossRef
5.
Zurück zum Zitat Seki A, Hori S, Kobayashi K, Narumiya S. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol. 2011;34:557–65.PubMedCrossRef Seki A, Hori S, Kobayashi K, Narumiya S. Transcatheter arterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for 135 hepatocellular carcinoma patients: single-center experience. Cardiovasc Intervent Radiol. 2011;34:557–65.PubMedCrossRef
6.
Zurück zum Zitat Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108–16.PubMedCrossRef Osuga K, Hori S, Hiraishi K, Sugiura T, Hata Y, Higashihara H, et al. Bland embolization of hepatocellular carcinoma using superabsorbent polymer microspheres. Cardiovasc Intervent Radiol. 2008;31:1108–16.PubMedCrossRef
7.
Zurück zum Zitat Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Intervent Radiol. 2013;36:1527–35.PubMedCrossRef Seki A, Hori S, Sueyoshi S, Hori A, Kono M, Murata S, et al. Transcatheter arterial embolization with spherical embolic agent for pulmonary metastases from renal cell carcinoma. Cardiovasc Intervent Radiol. 2013;36:1527–35.PubMedCrossRef
8.
Zurück zum Zitat Jiaqi Y, Hori S, Minamitani K, Hashimoto T, Yoshimura H, Nomura N, et al. A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nihon Igaku Hoshasen Gakkai Zasshi. 1996;56:19–24.PubMed Jiaqi Y, Hori S, Minamitani K, Hashimoto T, Yoshimura H, Nomura N, et al. A new embolic material: super absorbent polymer (SAP) microsphere and its embolic effects. Nihon Igaku Hoshasen Gakkai Zasshi. 1996;56:19–24.PubMed
9.
Zurück zum Zitat Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, et al. Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 µm. Safety and efficacy study. Cardiovasc Intervent Radiol. 2014;37:165–75.PubMedPubMedCentralCrossRef Malagari K, Pomoni M, Moschouris H, Kelekis A, Charokopakis A, Bouma E, et al. Chemoembolization of hepatocellular carcinoma with HepaSphere 30–60 µm. Safety and efficacy study. Cardiovasc Intervent Radiol. 2014;37:165–75.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.PubMedCrossRef Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60.PubMedCrossRef
11.
Zurück zum Zitat Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192–8.PubMedCrossRef Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol. 2000;15:1192–8.PubMedCrossRef
Metadaten
Titel
Management of vascular lake phenomenon on angiography during chemoembolization with superabsorbent polymer microspheres
verfasst von
Akihiko Seki
Shinichi Hori
Chigusa Shimono
Publikationsdatum
01.12.2015
Verlag
Springer Japan
Erschienen in
Japanese Journal of Radiology / Ausgabe 12/2015
Print ISSN: 1867-1071
Elektronische ISSN: 1867-108X
DOI
https://doi.org/10.1007/s11604-015-0486-2

Weitere Artikel der Ausgabe 12/2015

Japanese Journal of Radiology 12/2015 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.